Table 1. Point-of-care Testing (POCT) for Tumor Marker Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Point-of-care Testing (POCT) for Tumor Marker Market Restraints

Table 3. Point-of-care Testing (POCT) for Tumor Marker Market Trends

Table 4. Point-of-care Testing (POCT) for Tumor Marker Industry Policy

Table 5. Global Point-of-care Testing (POCT) for Tumor Marker Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Point-of-care Testing (POCT) for Tumor Marker Revenue Share by Company, 2019-2024, Ranked by Data of 2024

Table 7. Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Company, 2019-2024, Ranked by Data of 2024

Table 9. Global Point-of-care Testing (POCT) for Tumor Marker Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)

Table 10. Global Point-of-care Testing (POCT) for Tumor Marker Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Point-of-care Testing (POCT) for Tumor Marker Mergers & Acquisitions, Expansion Plans

Table 12. Global Point-of-care Testing (POCT) for Tumor Marker Manufacturers Product Type

Table 13. Head Office and Point-of-care Testing (POCT) for Tumor Marker Production Site of Key Manufacturer

Table 14. Point-of-care Testing (POCT) for Tumor Marker Capacity of Major Manufacturers and Future Plan

Table 15. China Point-of-care Testing (POCT) for Tumor Marker Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2024

Table 16. China Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2024

Table 17. China Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Company, 2019-2024, Ranked by Data of 2024

Table 18. Global Point-of-care Testing (POCT) for Tumor Marker Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 19. Global Point-of-care Testing (POCT) for Tumor Marker Production by Region, 2019-2024, (K Units)

Table 20. Global Point-of-care Testing (POCT) for Tumor Marker Production Forecast by Region, 2024-2030, (K Units)

Table 21. Global Key Players of Point-of-care Testing (POCT) for Tumor Marker Upstream (Raw Materials)

Table 22. Global Point-of-care Testing (POCT) for Tumor Marker Typical Customers

Table 23. Point-of-care Testing (POCT) for Tumor Marker Typical Distributors

Table 24. By Type, Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 25. By Application, Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 26. By Region, Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value, 2019 VS 2024 VS 2030, US$ Million

Table 27. By Region, Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value, 2019-2030, US$ Million

Table 28. By Region, Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, 2019-2030, (K Units)

Table 29. By Country, Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Country, Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value, 2019-2030, US$ Million

Table 31. By Country, Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value Market Share, 2019-2030

Table 32. By Country, Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, 2019-2030, (K Units)

Table 33. By Country, Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2019-2030

Table 34. Roche Company Information, Head Office, Market Area, and Industry Position

Table 35. Roche Point-of-care Testing (POCT) for Tumor Marker Models, Specifications, and Application

Table 36. Roche Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 37. Roche Company Profile and Main Business

Table 38. Roche Recent Developments

Table 39. Abbott Company Information, Head Office, Market Area, and Industry Position

Table 40. Abbott Point-of-care Testing (POCT) for Tumor Marker Models, Specifications, and Application

Table 41. Abbott Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Abbott Company Profile and Main Business

Table 43. Abbott Recent Developments

Table 44. BioMerieux Company Information, Head Office, Market Area, and Industry Position

Table 45. BioMerieux Point-of-care Testing (POCT) for Tumor Marker Models, Specifications, and Application

Table 46. BioMerieux Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. BioMerieux Company Profile and Main Business

Table 48. BioMerieux Recent Developments

Table 49. Wondfo Biotech Company Information, Head Office, Market Area, and Industry Position

Table 50. Wondfo Biotech Point-of-care Testing (POCT) for Tumor Marker Models, Specifications, and Application

Table 51. Wondfo Biotech Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Wondfo Biotech Company Profile and Main Business

Table 53. Wondfo Biotech Recent Developments

Table 54. Yuwell Company Information, Head Office, Market Area, and Industry Position

Table 55. Yuwell Point-of-care Testing (POCT) for Tumor Marker Models, Specifications, and Application

Table 56. Yuwell Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Yuwell Company Profile and Main Business

Table 58. Yuwell Recent Developments

Table 59. Getein Biotech Company Information, Head Office, Market Area, and Industry Position

Table 60. Getein Biotech Point-of-care Testing (POCT) for Tumor Marker Models, Specifications, and Application

Table 61. Getein Biotech Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Getein Biotech Company Profile and Main Business

Table 63. Getein Biotech Recent Developments

Table 64. Beijing Wantai BioPharm Company Information, Head Office, Market Area, and Industry Position

Table 65. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Tumor Marker Models, Specifications, and Application

Table 66. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Beijing Wantai BioPharm Company Profile and Main Business

Table 68. Beijing Wantai BioPharm Recent Developments

Table 69. Assure Tech Company Information, Head Office, Market Area, and Industry Position

Table 70. Assure Tech Point-of-care Testing (POCT) for Tumor Marker Models, Specifications, and Application

Table 71. Assure Tech Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Assure Tech Company Profile and Main Business

Table 73. Assure Tech Recent Developments

Table 74. Randox Company Information, Head Office, Market Area, and Industry Position

Table 75. Randox Point-of-care Testing (POCT) for Tumor Marker Models, Specifications, and Application

Table 76. Randox Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Randox Company Profile and Main Business

Table 78. Randox Recent Developments

Table 79. Orient Gene Company Information, Head Office, Market Area, and Industry Position

Table 80. Orient Gene Point-of-care Testing (POCT) for Tumor Marker Models, Specifications, and Application

Table 81. Orient Gene Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Orient Gene Company Profile and Main Business

Table 83. Orient Gene Recent Developments

Table 84. Hangzhou Biotest Company Information, Head Office, Market Area, and Industry Position

Table 85. Hangzhou Biotest Point-of-care Testing (POCT) for Tumor Marker Models, Specifications, and Application

Table 86. Hangzhou Biotest Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Hangzhou Biotest Company Profile and Main Business

Table 88. Hangzhou Biotest Recent Developments

Table 89. Shenzhen YHLO Company Information, Head Office, Market Area, and Industry Position

Table 90. Shenzhen YHLO Point-of-care Testing (POCT) for Tumor Marker Models, Specifications, and Application

Table 91. Shenzhen YHLO Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Shenzhen YHLO Company Profile and Main Business

Table 93. Shenzhen YHLO Recent Developments

Table 94. Qingdao Hightop Biotech Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 95. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Tumor Marker Models, Specifications, and Application

Table 96. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Qingdao Hightop Biotech Co., Ltd. Company Profile and Main Business

Table 98. Qingdao Hightop Biotech Co., Ltd. Recent Developments

Table 99. Getein Biotech, Inc. Company Information, Head Office, Market Area, and Industry Position

Table 100. Getein Biotech, Inc. Point-of-care Testing (POCT) for Tumor Marker Models, Specifications, and Application

Table 101. Getein Biotech, Inc. Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Getein Biotech, Inc. Company Profile and Main Business

Table 103. Getein Biotech, Inc. Recent Developments

Table 104. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Company Information, Head Office, Market Area, and Industry Position

Table 105. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Tumor Marker Models, Specifications, and Application

Table 106. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Company Profile and Main Business

Table 108. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments

List of Figures

Figure 1. Point-of-care Testing (POCT) for Tumor Marker Picture

Figure 2. Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value, (US$ million) & (2019-2030)

Figure 3. Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, (K Units) & (2019-2030)

Figure 4. Global Point-of-care Testing (POCT) for Tumor Marker Average Selling Price (ASP), (2019-2030) & (US$/Unit)

Figure 5. China Point-of-care Testing (POCT) for Tumor Marker Consumption Value, (US$ million) & (2019-2030)

Figure 6. China Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (K Units) & (2019-2030)

Figure 7. China Point-of-care Testing (POCT) for Tumor Marker Average Selling Price (ASP), (US$/Unit) & (2019-2030)

Figure 8. By Consumption Value, China Point-of-care Testing (POCT) for Tumor Marker Market Share of Global, 2019-2030

Figure 9. By Sales Quantity, China Point-of-care Testing (POCT) for Tumor Marker Market Share of Global, 2019-2030

Figure 10. Global Point-of-care Testing (POCT) for Tumor Marker Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Point-of-care Testing (POCT) for Tumor Marker Key Participants, Market Share, 2024

Figure 12. Global Point-of-care Testing (POCT) for Tumor Marker Capacity, Production and Capacity Utilization, 2019-2030

Figure 13. Global Point-of-care Testing (POCT) for Tumor Marker Capacity Market Share by Region, 2024 VS 2030

Figure 14. Global Point-of-care Testing (POCT) for Tumor Marker Production Market Share & Forecast by Region, 2019-2030

Figure 15. Point-of-care Testing (POCT) for Tumor Marker Industry Chain

Figure 16. Point-of-care Testing (POCT) for Tumor Marker Procurement Model

Figure 17. Point-of-care Testing (POCT) for Tumor Marker Sales Model

Figure 18. Point-of-care Testing (POCT) for Tumor Marker Sales Channels, Direct Sales, and Distribution

Figure 19. Based on Immunochromatography

Figure 20. Based on Chemiluminescence Technology

Figure 21. Based on Biosensor

Figure 22. Others

Figure 23. By Type, Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value, 2019-2030, US$ Million

Figure 24. By Type, Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value Market Share, 2019-2030

Figure 25. By Type, Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, 2019-2030, (K Units)

Figure 26. By Type, Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2019-2030

Figure 27. By Type, Global Point-of-care Testing (POCT) for Tumor Marker Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 28. Hospital

Figure 29. lndependent Testing Organization

Figure 30. By Application, Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value, 2019-2030, US$ Million

Figure 31. By Application, Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value Market Share, 2019-2030

Figure 32. By Application, Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, 2019-2030, (K Units)

Figure 33. By Application, Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2019-2030

Figure 34. By Application, Global Point-of-care Testing (POCT) for Tumor Marker Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 35. By Region, Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value Market Share, 2019-2030

Figure 36. By Region, Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2019-2030

Figure 37. North America Point-of-care Testing (POCT) for Tumor Marker Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 38. By Country, North America Point-of-care Testing (POCT) for Tumor Marker Consumption Value Market Share, 2024

Figure 39. Europe Point-of-care Testing (POCT) for Tumor Marker Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 40. By Country, Europe Point-of-care Testing (POCT) for Tumor Marker Consumption Value Market Share, 2024

Figure 41. Asia Pacific Point-of-care Testing (POCT) for Tumor Marker Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 42. By Country/Region, Asia Pacific Point-of-care Testing (POCT) for Tumor Marker Consumption Value Market Share, 2024

Figure 43. South America Point-of-care Testing (POCT) for Tumor Marker Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, South America Point-of-care Testing (POCT) for Tumor Marker Consumption Value Market Share, 2024

Figure 45. Middle East & Africa Point-of-care Testing (POCT) for Tumor Marker Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 46. U.S. Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, 2019-2030, (K Units)

Figure 47. By Type, U.S. Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 48. By Application, U.S. Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 49. Europe Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, 2019-2030, (K Units)

Figure 50. By Type, Europe Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 51. By Application, Europe Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 52. China Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, 2019-2030, (K Units)

Figure 53. By Type, China Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 54. By Application, China Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 55. Japan Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, 2019-2030, (K Units)

Figure 56. By Type, Japan Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 57. By Application, Japan Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 58. South Korea Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, 2019-2030, (K Units)

Figure 59. By Type, South Korea Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 60. By Application, South Korea Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 61. Southeast Asia Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, 2019-2030, (K Units)

Figure 62. By Type, Southeast Asia Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 63. By Application, Southeast Asia Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 64. India Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, 2019-2030, (K Units)

Figure 65. By Type, India Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 66. By Application, India Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 67. Middle East & Africa Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, 2019-2030, (K Units)

Figure 68. By Type, Middle East & Africa Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 69. By Application, Middle East & Africa Point-of-care Testing (POCT) for Tumor Marker Sales Quantity Market Share, 2024 VS 2030

Figure 70. Research Methodology

Figure 71. Breakdown of Primary Interviews

Figure 72. Bottom-up and Top-down Approaches

Figure 73. Top-down Approaches